Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?

被引:0
|
作者
Abrey, LE [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
来源
NATURE CLINICAL PRACTICE NEUROLOGY | 2006年 / 2卷 / 06期
关键词
brain metastasis; breast cancer; CNS; HER2; trastuzumab;
D O I
10.1038/ncpneuro0177
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:302 / 303
页数:2
相关论文
共 50 条
  • [41] Trastuzumab use and CNS metastasis in Medicare patients diagnosed with metastatic breast cancer (MBC)
    Griffiths, R.
    Lalla, D.
    Brammer, M.
    Herbert, R.
    Doan, J.
    Danese, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
    Montemurro, F
    Aglietta, M
    CANCER, 2005, 103 (06) : 1314 - 1315
  • [43] Does consuming isoflavones reduce or increase breast cancer risk?
    Bondesson, Maria
    Gustafsson, Jan-Ake
    GENOME MEDICINE, 2010, 2
  • [45] Does consuming isoflavones reduce or increase breast cancer risk?
    Maria Bondesson
    Jan-Ake Gustafsson
    Genome Medicine, 2
  • [46] DOES DELAYING PREGNANCY INCREASE THE RISK OF BREAST-CANCER
    DOLEZAL, JM
    MCFARLANE, MJ
    CLINICAL RESEARCH, 1988, 36 (03): : A346 - A346
  • [47] Does a high folate intake increase the risk of breast cancer?
    Kim, Young-In
    NUTRITION REVIEWS, 2006, 64 (10) : 468 - 475
  • [48] TRASTUZUMAB TREATMENT IN PATIENT WITH BREAST CANCER AND METASTATIC CNS DISEASE
    Perrucci, B.
    Montrone, M.
    Luccarelli, G.
    Lotesoriere, C.
    Nenna, C.
    D'Alessandro, A. R.
    Fanelli, F.
    Pisconti, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S102 - S102
  • [49] Risk factors for central nervous system (CNS) metastases in patients with stage I-III breast cancer
    Neciosup, S. P.
    Gomez, H. L.
    Cruz, W. R.
    Doimi, F. F.
    Pinto, J. A.
    Cotrina, J. M.
    Suazo, J. F.
    Carlos, V. E.
    Mauricio, L.
    Vallejos Sologuren, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
    Lai, R
    Dang, CT
    Malkin, MG
    Abrey, LE
    CANCER, 2004, 101 (04) : 810 - 816